MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Regulation FD Disclosure

19

MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Files An 8-K Regulation FD Disclosure

Item 7.01

Regulation FD Disclosure.

The Registrant is hereby furnishing the following information
under Regulation FD:

On March 20, 2017, the Registrant issued a press release
announcing that its Board of Directors has declared monthly cash
dividends for its 11% Series A Cumulative Redeemable Perpetual
Preferred Stock (Series A Preferred Stock) for March through May
2017.

A copy of the press release is attached hereto as Exhibit 99.1
and incorporated herein by reference.

Safe Harbor Statement

Statements contained in the exhibit to report that state the
Companys or its managements expectations or predictions of the
future are forward-looking statements intended to be covered by
the safe harbor provisions of the Securities Act of 1933, as
amended, and the Securities Exchange Act of 1934, as amended. It
is important to note that the Companys actual results could
differ materially from those projected in such forward-looking
statements. The Company does not assume any obligations to update
the forward-looking statements provided to reflect events that
occur or circumstances that exist after the date on which they
were made.

Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
99.1 Press Release issued March 20, 2017 by Medical Transcription
Billing, Corp.

(S)


MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) Recent Trading Information

MEDICAL TRANSCRIPTION BILLING, CORP. (NASDAQ:MTBCP) closed its last trading session 00.00 at 25.40 with 777 shares trading hands.

An ad to help with our costs